ES2156858T3 - Reactivo de diagnostico para hepatitis c. - Google Patents

Reactivo de diagnostico para hepatitis c.

Info

Publication number
ES2156858T3
ES2156858T3 ES92117191T ES92117191T ES2156858T3 ES 2156858 T3 ES2156858 T3 ES 2156858T3 ES 92117191 T ES92117191 T ES 92117191T ES 92117191 T ES92117191 T ES 92117191T ES 2156858 T3 ES2156858 T3 ES 2156858T3
Authority
ES
Spain
Prior art keywords
hepatitis
diagnostic reagent
virus
antibody
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117191T
Other languages
English (en)
Inventor
Tatsuo Miyamura
Izumu Saito
Shizuko Harada
Yoshikazu Honda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JP AGENCY OF NAT INST OF INFEC
National Institute of Infectious Diseases
Original Assignee
JP AGENCY OF NAT INST OF INFEC
National Institute of Infectious Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JP AGENCY OF NAT INST OF INFEC, National Institute of Infectious Diseases filed Critical JP AGENCY OF NAT INST OF INFEC
Application granted granted Critical
Publication of ES2156858T3 publication Critical patent/ES2156858T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PRESENTA UN REAGENTE DE DIAGNOSTICO PARA LA HEPATITIS C, QUE DETECTA UN ANTICUERPO INDUCIDO POR LA INFECCION DEL VIRUS DE LA HEPATITIS C, EL REAGENTE SE CARACTERIZA EN QUE COMPRENDE LA SEGUNDA PROTEINA DE LA CUBIERTA DE LA PRIMERA PROTEINA NO ESTRUCTURAL QUE ESTA CODIFICADA POR EL GEN DEL VIRUS DE LA HEPATITIS C Y TIENE UNA CADENA "SUGER". LA INVENCION TAMBIEN SUMINISTRA UN METODO PARA DETECTAR UN ANTICUERPO DEL VIRUS DE LA ANTI-HEPATITIS C. EL USO DEL REAGENTE DE DIAGNOSTICO PARA LA HEPATITIS C, DE ACUERDO CON LA INVENCION, HACE POSIBLE UNA DIAGNOSIS ALTAMENTE SENSIBLE DE LA HEPATITIS C.
ES92117191T 1991-10-08 1992-10-08 Reactivo de diagnostico para hepatitis c. Expired - Lifetime ES2156858T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26082491A JP3158177B2 (ja) 1991-10-08 1991-10-08 Ｃ型肝炎診断薬

Publications (1)

Publication Number Publication Date
ES2156858T3 true ES2156858T3 (es) 2001-08-01

Family

ID=17353272

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117191T Expired - Lifetime ES2156858T3 (es) 1991-10-08 1992-10-08 Reactivo de diagnostico para hepatitis c.

Country Status (7)

Country Link
US (2) US5750331A (es)
EP (1) EP0537626B1 (es)
JP (1) JP3158177B2 (es)
AT (1) ATE199596T1 (es)
CA (1) CA2080213C (es)
DE (1) DE69231719T2 (es)
ES (1) ES2156858T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05344899A (ja) * 1992-06-11 1993-12-27 Kokuritsu Yobou Eisei Kenkyusho Ｃ型肝炎ウイルス外被タンパク質の産生法
EP0773029A4 (en) * 1993-07-19 1997-09-03 Tokyo Tanabe Co HEPATITIS C VIRUS PROLIFERATION INHIBITOR
EP1845108A3 (en) 1994-07-29 2007-10-24 Innogenetics N.V. Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US8168771B2 (en) * 2005-01-31 2012-05-01 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
CN102645534B (zh) * 2012-04-26 2015-08-12 杭州市萧山区第一人民医院 基于量子点编码微球芯片检测丙型肝炎病毒的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
FI913068A7 (fi) * 1990-06-25 1991-12-26 The Res Foundation For Microbial Ei-A-, ei-B-hepatiittiviruspartikkelit
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
DE69131882T3 (de) * 1990-11-08 2007-05-24 Novartis Vaccines and Diagnostics, Inc., Emeryville Asiloglycoproteine des hepatitis c-virus
CA2070952A1 (en) * 1991-06-11 1992-12-12 Makoto Seki Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same

Also Published As

Publication number Publication date
EP0537626B1 (en) 2001-03-07
JP3158177B2 (ja) 2001-04-23
JPH05142231A (ja) 1993-06-08
US5750331A (en) 1998-05-12
EP0537626A1 (en) 1993-04-21
DE69231719T2 (de) 2001-07-12
CA2080213A1 (en) 1993-04-09
DE69231719D1 (de) 2001-04-12
ATE199596T1 (de) 2001-03-15
CA2080213C (en) 2003-02-18
US5747241A (en) 1998-05-05

Similar Documents

Publication Publication Date Title
UA42668C2 (uk) Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти)
FI20021626L (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
EP0468527A3 (en) Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
AU655592B2 (en) Hepatitis C assay utilizing recombinant antigens
PT733069E (pt) Antigenios ctla-8 de primata purificados e reagentes relacionados
DK480889D0 (da) Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna
AU6839090A (en) Hepatitis c assay
ES2091765T3 (es) Procedimiento de deteccion e identificacion de constituyentes que contienen acido nucleico.
DE69027812D1 (de) Verfahren zur Zurichtung eines verbesserten Western-Blott-Immuntestverfahrens
FI935217A0 (fi) Basisk dissocieringsanalys
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
ATE191088T1 (de) Verfahren zum nachweis einer rinderdiarrhoe- virusinfektion, für ein durch eine infektion mit diesem virus induziertes eiweiss kodierende nukleotidsequenz, sowie daraus abgeleitete rekombinante eiweisse und antigene
ATE199596T1 (de) Diagnostisches reagenz für hepatitis c
DK0649904T3 (da) Diagnostisk reagens til påvisning af antistoffer mod EBV
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
FI881355A7 (fi) Määritysmenetelmä hepatiittiantigeenien ja AIDS-vasta-aineiden toteamiseksi.
DE3789597D1 (de) Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia.
DE69119445D1 (de) Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus)
PT1028127E (pt) Anticorpos e metodos de diagnostico para o diagnostico de pestivirus
DE3578742D1 (de) Verfahren zur bestimmung der antikoerper vom herpes-simplex-virus.
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
FI920910A0 (fi) Peptider som foermaor reagera immunokemiskt med antikroppar mot hepatit ej-a, ej-b -virus.
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
KR930007970A (ko) 비-에이 형 , 비-비형 펩티드

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537626

Country of ref document: ES